LODOZ

This brand name is authorized in Croatia, Estonia, France, Hong Kong SAR China, Italy, Nigeria, Romania, Turkey.

Active ingredients

The drug LODOZ contains a combination of these active pharmaceutical ingredients (APIs):

1	Bisoprolol UNII UR59KN573L - BISOPROLOL FUMARATE
	Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity.
	Read more about Bisoprolol
2	Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07BB07	Bisoprolol and thiazides	C Cardiovascular system → C07 Beta blocking agents → C07B Beta blocking agents and thiazides → C07BB Beta blocking agents, non-selective, and thiazides
Discover more medicines within C07BB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1137934
FR	Base de données publique des médicaments	65118181, 66845664, 67460027
HK	Department of Health Drug Office	46865, 49030
HR	Agencija za lijekove i medicinske proizvode	HR-H-374007129, HR-H-693599830, HR-H-721781521
IT	Agenzia del Farmaco	035583018, 035583069, 035583119
NG	Registered Drug Product Database	B4-8901, B4-8902, B4-9830
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66295001, W66295002, W66295003, W66296001, W66296002, W66296003, W66297001, W66297002, W66297003
TR	İlaç ve Tıbbi Cihaz Kurumu	8699228090065